CONCLUSION
ESUS patients were older and had a higher prevalence of diabetes and hypertension, while active smoking was more common among migraine patients. Echocardiographic assessments showed no significant differences in heart dimensions or valvular issues. However, ESUS patients had higher pulmonary artery systolic pressure (PASP). ESUS patients showed more microbubble crossings through the interatrial septum (IAS) and longer PFOs. While the RoPe score was similar, the High-risk PFO score was slightly higher in ESUS patients. This study highlights differences between migraine and ESUS patients in terms of some demographic, comorbid, and echocardiographic parameters.
  1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17–20.
  2. Andrews R, Tulloh R, Magee A, et al. Atrial septal defect with failure to thrive in infancy: hidden pulmonary vascular disease. Pediatr Cardiol 2002;23:528-30.
  3. Lammers A, Hager A, Eicken A, et al. Need for closure of secundum atrial septal defect in infancy. J Thorac Cardiovasc Surg 2005;129:1353-57.
  4. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148–52.
  5. Liu K, Wang BZ, Hao Y, et al. The Correlation Between Migraine and Patent Foramen Ovale. Frontiers in Neurology 2020;11.
  6. Naqvi N, McCarthy KP, Ho SY. Anatomy of the atrial septum and interatrial communications. Journal of Thoracic Disease 2018;10(Suppl 24), S2837.
  7. Hibi N, Kambe T, Itoh K, et al. Cross-sectional echocardiographic study on atrial septal defect: pre- and postoperative considerations. Japanese heart journal 1986;23(2), 147–159.
  8. Rozensweig BP, Nayar AC, Varkey MP, et al. Echo contrast enhanced diagnosis of atrial septal defect. J Am Soc Echocardiogr 2001;14:155-57.
  9. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740–6.
  10. Falanga, G., Carerj, S., Oreto, G., Khandheria, B. K., & Zito, C. (2014). How to Understand Patent Foramen Ovale Clinical Significance: Part I. Journal of cardiovascular echography24 (4), 114–121.
  11. Lucà, F., Pino, P. G., Parrini, I., Di Fusco, S. A., Ceravolo, R., Madeo, A., Leone, A., La Mair, M., Benedetto, F. A., Riccio, C., Oliva, F., Colivicchi, F., Gulizia, M. M., & Gelsomino, S. (2023). Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management. Journal of clinical medicine12 (5), 1952.
  12. Nakayama R, Takaya Y, Akagi T, Watanabe N, Ikeda M, Nakagawa K, Toh N, Ito H.. Identification of high risk patent foramen ovale associated with cryptogenic stroke: development of a scoring system. J Am Soc Echocardiogr  2019;32:811–816.
  13. Radico, F., Foglietta, M., Di Fulvio, M., Appignani, M., Rossi, S., Angelis, M. V., Gallina, S., & Zimarino, M. (2021). The ’dreaded PFO’: anatomical and functional features of high risk for stroke. European heart journal supplements : journal of the European Society of Cardiology23 (Suppl E), E189–E193.
  14. Kent DM, Ruthazer R, Weimar C, Mas J-L, Serena J, S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MSV, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono M-L, Nedeltchev K, Papetti F, Thaler DE.. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology  2013;81:619–625.
  15. Van der Giessen, H., Wilson, L. C., Coffey, S., & Whalley, G. A. (2020). Review: Detection of patient foramen ovale using transcranial Doppler or standard echocardiography. Australasian journal of ultrasound in medicine23 (4), 210–219.
  16. Ioannidis, S. G., & Mitsias, P. D. (2020). Patent Foramen Ovale in Cryptogenic Ischemic Stroke: Direct Cause, Risk Factor, or Incidental Finding?. Frontiers in neurology11 , 567.
  17. Tobis, M. J., & Azarbal, B. (2005). Does patent foramen ovale promote cryptogenic stroke and migraine headache?. Texas Heart Institute journal32 (3), 362–365.
  18. W, Shen Y, Zhong J, et al. The Patent Foramen Ovale and Migraine: Associated Mechanisms and Perspectives from MRI Evidence. Brain Sciences 2022; 12(7):941.
  19. Homma S, Di Tullio MR, Sacco RL, et al. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994;25:582–6.
  20. Stone DA, Godard J, Corretti MC, et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996;131:158–61.
  21. Fuse S, Tomita H, Hatakeyama K, et al. Effect of a secundum atrial septal defect on shunt volume. Am J Cardiol 2001;88:1447-50.
  22. Schuchlenz HW, Saurer G, Weihs W, et al. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr 2004;17:231–3.
  23. Gin KG, Huckell VF, Pollick C. Femoral vein delivery of contrast medium enhances transthoracic echocardiographic detection of patent foramen ovale. J Am Coll Cardiol 1993;22:1994–2000.
Table 1 Baseline clinical and echocardiographic characteristics of the study population
Table 2 Comparison of basal characteristics and echocardiographic features by study groups
Figure 1 Comparison of PFO height and PFO length measurements in migraine and ESUS patients with Box Plot graph
Figure 2 Comparison of RoPe score and anatomical and functional high-risk PFO score in migraine and ESUS patients with Box Plot graph